Tricuspid stenosis screening: Difference between revisions
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Tricuspid stenosis}} | {{Tricuspid stenosis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} [[User:Mohammed Salih|Mohammed Salih, M.D.]] {{sali}} | ||
==Overview== | ==Overview== | ||
Revision as of 21:36, 1 April 2020
Tricuspid stenosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tricuspid stenosis screening On the Web |
American Roentgen Ray Society Images of Tricuspid stenosis screening |
Risk calculators and risk factors for Tricuspid stenosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Salih, M.D. Syed Musadiq Ali M.B.B.S.[2]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]